This article carries a critical qualifier before it begins: the comparative evidence applies to mild-to-moderate presentations. For severe depression, medication and combined treatment are more effective. If you are experiencing significant symptoms, speaking with a qualified clinician is the right first step. What the research establishes is that for the presentations most commonly encountered in entrepreneurial contexts — the persistent low mood, elevated anxiety, and cognitive dulling of sustained stress — the evidence base for exercise is now stronger than the evidence base for first-line medication, and the mechanism explains why.

BDNF and the neuroplasticity pathway exercise and antidepressants share

Cotman and Berchtold’s 2002 Nature Reviews Neuroscience paper established that aerobic exercise robustly increases brain-derived neurotrophic factor — the primary molecular signal for neuroplasticity, synaptic strengthening, and hippocampal neurogenesis. Reduced hippocampal volume is one of the most consistently replicated neurological findings in major depression. The hippocampus plays a central role in emotional regulation, stress response modulation, and the consolidation of positive emotional memories. Both antidepressant medications and exercise restore hippocampal volume and function through BDNF — but through different pathways that converge on the same therapeutic target.

Antidepressants primarily modulate monoamine neurotransmitter systems — serotonin, norepinephrine, dopamine — and secondarily produce neuroplastic effects through BDNF. Exercise produces neuroplastic effects directly through the PGC-1α/FNDC5/irisin pathway and secondarily modulates monoamine systems through increased turnover. Both reach hippocampal neurogenesis. The difference is that exercise bypasses the monoamine mechanism entirely — which is relevant to the substantial proportion of patients who do not respond to SSRI treatment, and to the understanding of why exercise and medication produce additive rather than redundant effects when combined.

The dose-response meta-analysis by Yuping and colleagues confirmed that combined aerobic plus resistance exercise produces the largest BDNF elevations, with optimal antidepressant effects peaking at approximately 150 minutes of moderate-intensity exercise per week — the standard public health recommendation. The minimum effective dose for neuroplastic benefit is 8 to 12 weeks of consistent training. The 12-week threshold mirrors the standard clinical trial duration for assessing pharmacological antidepressants, which is not coincidental: both are measuring the same neuroplastic process.

Exercise trains the stress response rather than modulating it chemically

Fleshner’s exercise-stress inoculation model proposes that regular aerobic exercise trains the HPA axis through repeated voluntary stress exposure. Exercise produces the same physiological signatures as stress — elevated heart rate, elevated cortisol, metabolic demand — followed by recovery. This cycle, repeated consistently, trains the HPA axis to activate more efficiently and recover more rapidly. The result is a trained stress response that produces lower peak cortisol and faster return to baseline when facing the same psychological stressor.

This is the mechanistic difference that explains exercise’s durability advantage over medication. Antidepressants chemically modulate the HPA axis while the treatment is active; when treatment ends, the modulation ends. Exercise produces structural changes in the HPA axis calibration that persist after the exercise itself — because the training effect is neurobiological rather than chemical. Blumenthal and colleagues’ long-term follow-up of the landmark Duke University trial found that exercise-only patients had significantly lower relapse rates than medication-only patients at ten months — the durability advantage the inoculation model predicts.

The 2024 BMJ meta-analysis: the comparative evidence

Noetel and colleagues’ 2024 British Medical Journal network meta-analysis is the largest comparative analysis of exercise and depression treatment conducted. 218 randomised controlled trials, 14,170 participants. Exercise showed effect sizes 1.5 times larger than antidepressant medication for mild-to-moderate depression. The combination of exercise plus medication produced the largest effects. Walking, jogging, yoga, strength training, and mixed aerobic exercise all produced significant antidepressant effects, with effect sizes consistently in the moderate-to-large range.

The 218-RCT evidence base for exercise is comparable to the evidence base for SSRIs. The absence of exercise as a first-line recommended treatment for mild-to-moderate depression in most clinical guidelines represents a gap between the evidence and practice that this meta-analysis is beginning to close. For the practising entrepreneur experiencing the low-grade persistent depression of chronic stress load, the most empirically supported intervention available is 150 minutes of exercise per week for 12 weeks — not as a complement to treatment but as the primary treatment.

The anxiolytic mechanism: exercise as interoceptive exposure

Salmon’s 2001 Neuroscience and Biobehavioral Reviews paper proposed the anxiolytic mechanism that explains why exercise reduces anxiety through a pathway distinct from its antidepressant effects. The physiological sensations of aerobic exercise — elevated heart rate, increased respiration, sweating, physical discomfort — are substantially similar to the physiological sensations of anxiety. For anxious individuals who have developed fear of their own physiological arousal, regular exercise provides a benign context for experiencing these sensations repeatedly without the expected catastrophic outcome.

This is functionally equivalent to the interoceptive exposure that cognitive-behavioural treatment uses for panic disorder — and it explains why the anxiolytic effects of exercise are particularly strong in anxiety-sensitive populations. Each exercise session provides repeated disconfirmation of the belief that physiological arousal is dangerous. The HPA inoculation effect compounds this: the person who exercises regularly has a lower-reactivity HPA axis and lower peak anxiety response to the same stressor. The anxiety reduction is both mechanistic — trained HPA — and cognitive — repeated safe exposure to feared physiological sensations.

The neurochemistry of the immediate mood effect

The immediate mood elevation of acute exercise operates through three parallel neurochemical pathways. Endorphin release produces opioid receptor activation with analgesia and euphoria. Endocannabinoid release — specifically anandamide — produces anxiolysis and positive affect through the same receptor system targeted by cannabis. Monoamine turnover increases serotonin, norepinephrine, and dopamine synthesis and release. Raichlen and colleagues’ 2012 research established that anandamide may be the primary mechanism for the acute subjective mood effects of aerobic exercise — anandamide crosses the blood-brain barrier readily, while endorphins do not — which resolves the longstanding puzzle of why the runner’s high is not adequately explained by beta-endorphin alone.

The immediate mood effect is the entry mechanism. The 8-to-12-week neuroplastic effect is the therapeutic mechanism. The ongoing HPA calibration is the relapse-prevention mechanism. All three operate independently and compound across sustained exercise practice.

The twin study evidence for exercise’s independent causal effect

Twin studies from the Swedish Twin Registry document that within-pair differences in exercise levels predict within-pair differences in depression outcomes — even when controlling for genetic predisposition to both depression and exercise behaviour. The twin who exercises regularly shows lower depression rates than their genetically identical sibling who does not. The exercise effect on depression is not confounded by genetic predisposition to wellbeing, establishing a causal pathway that the mechanistic research now fully explains.

Book worth reading on this

Spark: The Revolutionary New Science of Exercise and the Brain by John Ratey is the foundational popular synthesis of the exercise-brain research and remains the most complete accessible account of the BDNF mechanism, the antidepressant comparison, and the anxiety-reduction mechanisms available in a single volume. Ratey was writing before the 2024 BMJ meta-analysis but his coverage of the Blumenthal sertraline trial and the mechanistic evidence for exercise as antidepressant treatment is rigorous and specific. For any entrepreneur who is intellectually convinced that exercise matters but has not yet understood why it matters at the neurobiological level — and why that level of understanding changes the motivation calculation — this is the book that provides the mechanism with enough depth to make the prescription feel grounded rather than aspirational.

If the dynamics described here are significantly affecting your wellbeing, speaking with a psychologist is the right next step. UK: Samaritans (116 123, free, 24/7). Mind (0300 123 3393). BACP: bacp.co.uk/search/Therapists. Crisis Text Line — text HOME to 741741 (US, UK, Canada, Ireland). International: internationaltherapistdirectory.com.

This article is for educational and informational purposes only. Sources: Noetel, M. et al. (2024), Effect of Exercise for Depression: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials, British Medical Journal, 384, e075847. Cotman, C.W. & Berchtold, N.C. (2002), Exercise: A Behavioral Intervention to Enhance Brain Health and Plasticity, Trends in Neurosciences, 25(6), 295–301. Blumenthal, J.A. et al. (1999), Effects of Exercise Training on Older Patients with Major Depression, Archives of Internal Medicine, 159(19), 2349–2356. Blumenthal, J.A. et al. (2007), Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder, Psychosomatic Medicine, 69(7), 587–596. Fleshner, M. (2005), Physical Activity and Stress Resistance, Exercise and Sport Sciences Reviews, 33(3), 120–126. Raichlen, D.A. et al. (2012), Wired to Run: Exercise-Induced Endocannabinoid Signaling, Journal of Experimental Biology, 215(8), 1331–1336. Salmon, P. (2001), Effects of Physical Exercise on Anxiety, Depression, and Sensitivity to Stress, Clinical Psychology Review, 21(1), 33–61. Ratey, J. (2008), Spark, Little, Brown. McGonigal, K. (2019), The Joy of Movement, Avery. Lieberman, D. (2020), Exercised, Pantheon.